nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acetaldehyde exposure alters fibrin polymerization, fibrinolysis, and fibrin network structure in vitro
|
Rave, Shakthi |
|
|
9 |
4 |
p. |
artikel |
2 |
Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice
|
Sidonio Jr., Robert F. |
|
|
9 |
4 |
p. |
artikel |
3 |
Adenovirus vectors can infect mouse megakaryocytes – implications for vaccine-induced thrombosis/thrombocytopenia
|
Collett, Simon |
|
|
9 |
4 |
p. |
artikel |
4 |
Clinical and laboratory aspects of patients diagnosed with various inherited platelet disorders
|
Gök, Veysel |
|
|
9 |
4 |
p. |
artikel |
5 |
Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of disease
|
Englisch, Cornelia |
|
|
9 |
4 |
p. |
artikel |
6 |
Corrigendum to ‘Preemptive anticoagulation during antenatal pulmonary embolism diagnostics in a community setting: retrospective cohort study’
|
Campbell, Aidan R. |
|
|
9 |
4 |
p. |
artikel |
7 |
Development and validation of a genetic probability for venous thromboembolism
|
Shi, Zhuqing |
|
|
9 |
4 |
p. |
artikel |
8 |
Diagnostic accuracy of the international classification of disease “I26” code to detect acute pulmonary embolism in a surveillance network
|
Kline, Jeffrey A. |
|
|
9 |
4 |
p. |
artikel |
9 |
Editorial Board
|
|
|
|
9 |
4 |
p. |
artikel |
10 |
Effects on mortality of extended versus short-term anticoagulation in venous thromboembolism: a systematic review and meta-analysis of randomized trials
|
Lefebvre, Margot |
|
|
9 |
4 |
p. |
artikel |
11 |
Efficacy and safety of direct oral anticoagulants compared with warfarin in antiphospholipid syndrome. Results of a multicenter retrospective cohort study
|
Elsebaie, Maha A.T. |
|
|
9 |
4 |
p. |
artikel |
12 |
Endothelial heterogeneity shapes shear stress response: a transcriptomic perspective
|
Deng, Hanqiang |
|
|
9 |
4 |
p. |
artikel |
13 |
Evaluation of extended direct oral anticoagulant dosing strategies in patients with and without cancer from a prospective observational registry
|
Vlazny, Danielle T. |
|
|
9 |
4 |
p. |
artikel |
14 |
Exploration of biomarkers for inhibitor development in persons with hemophilia A
|
Fan, Meng-Ni |
|
|
9 |
4 |
p. |
artikel |
15 |
External validation of the DAYS score for suspected deep vein thrombosis
|
Halstensen, Thor–David |
|
|
9 |
4 |
p. |
artikel |
16 |
Gene-based therapies for hemophilia
|
Glasner, Melissa F. |
|
|
9 |
4 |
p. |
artikel |
17 |
Genetic analysis using long-read sequencing to overcome the difficulties in VWF gene
|
Ye, Sheng |
|
|
9 |
4 |
p. |
artikel |
18 |
Guidelines for management of hemophilia—why, what, and how?
|
Srivastava, Alok |
|
|
9 |
4 |
p. |
artikel |
19 |
Halo fluorescence fibrinolysis test: a novel quantitative assay to evaluate fibrinolysis on established plasma clots
|
Liu, Zikou |
|
|
9 |
4 |
p. |
artikel |
20 |
Identifying and addressing underuse in hematologic care through systems-based hematology
|
Cogan, Jacob C. |
|
|
9 |
4 |
p. |
artikel |
21 |
Impact of coronary revascularization on clinical outcomes of postacute myocardial infarction patients with left ventricular thrombus
|
Seah, Andre Wen–Jie |
|
|
9 |
4 |
p. |
artikel |
22 |
Impact of sampling technique, anticoagulant, processing delay, and temperature on murine platelet function in whole blood
|
Trivigno, Silvia Maria Grazia |
|
|
9 |
4 |
p. |
artikel |
23 |
Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry
|
Fischer, Kathelijn |
|
|
9 |
4 |
p. |
artikel |
24 |
Intraindividual variability of von Willebrand factor and the need for repeated testing
|
Kirkeby, Malene Helligsø |
|
|
9 |
4 |
p. |
artikel |
25 |
Investigating interassay variability between direct oral anticoagulant calibrated anti–factor Xa assays: a substudy of the perioperative anticoagulation use for surgery evaluation (PAUSE) trial
|
Baker, Ryan M. |
|
|
9 |
4 |
p. |
artikel |
26 |
In vivo activation of coagulation during human liver transplantation is associated with activation of the intrinsic pathway: an observational cohort study
|
Elvers, Fynn L. |
|
|
9 |
4 |
p. |
artikel |
27 |
Joint effects of atrial fibrillation and prothrombotic genotypes on the risk of venous thromboembolism
|
Hald, Erin Mathiesen |
|
|
9 |
4 |
p. |
artikel |
28 |
Longitudinal dynamics of hemostatic biomarkers in patients with cancer receiving immune checkpoint inhibitors vs chemotherapy: results from the Vienna CAT-BLED study
|
Vladic, Nikola |
|
|
9 |
4 |
p. |
artikel |
29 |
Menstrual bleeding-specific quality of life in women on antiplatelet therapy
|
Kempers, Eva K. |
|
|
9 |
4 |
p. |
artikel |
30 |
Neonatal intracardiac thrombosis secondary to transplacental transfer of maternal antiphospholipid antibodies-a case report and review of the literature
|
Girgulis, Katherine |
|
|
9 |
4 |
p. |
artikel |
31 |
Occurrence of an infectious complication may be a predictor of venous thromboembolism after surgery for colorectal cancer
|
van Cruchten, Stijn |
|
|
9 |
4 |
p. |
artikel |
32 |
Post–below-knee amputation venous thromboembolism and mortality in United States veterans
|
Nguyen, Khanh P. |
|
|
9 |
4 |
p. |
artikel |
33 |
Postoperative venous thromboembolism in transgender patients receiving estrogen-based hormone therapy
|
Kelmser, Ethan C. |
|
|
9 |
4 |
p. |
artikel |
34 |
Prevalence of heavy menstrual bleeding, iron deficiency, iron deficiency anemia, and treatment in women with von Willebrand disease—a cohort study
|
Myrin–Westesson, Linda |
|
|
9 |
4 |
p. |
artikel |
35 |
Probing rare von Willebrand disease–causing mutations in the D4 and C-domains of von Willebrand factor
|
Mobayen, Golzar |
|
|
9 |
4 |
p. |
artikel |
36 |
Risk of major bleeding in recurrent fallers receiving anticoagulation for atrial fibrillation: a prospective cohort study
|
Regina, Jean |
|
|
9 |
4 |
p. |
artikel |
37 |
SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis
|
Zhang, Quan |
|
|
9 |
4 |
p. |
artikel |
38 |
Strategies for anticoagulation in patients with thrombocytopenia and cancer-associated thrombosis (START): design and rationale of the START pilot randomized controlled trial
|
Wang, Tzu–Fei |
|
|
9 |
4 |
p. |
artikel |
39 |
The factor XIa antibody osocimab strongly inhibits clotting in extracorporeal circuits with human blood and in baboons
|
Samaha, Eslam |
|
|
9 |
4 |
p. |
artikel |
40 |
Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial
|
Lother, Sylvain A. |
|
|
9 |
4 |
p. |
artikel |
41 |
The role of factor V in trauma-induced coagulopathy: an observational and experimental study
|
Sloos, Pieter H. |
|
|
9 |
4 |
p. |
artikel |
42 |
Thrombocytopenia in critically ill trauma patients is associated with the pattern and duration of postinjury organ dysfunction
|
Rossetto, Andrea |
|
|
9 |
4 |
p. |
artikel |
43 |
Thrombotic risk determined by ABO, F8, and VWF variants in a population-based cohort study
|
Manderstedt, Eric |
|
|
9 |
4 |
p. |
artikel |
44 |
Tougher clots, safer lives? Revisiting the role of factor XIII in thrombus stability and embolization risk
|
Bagoly, Zsuzsa |
|
|
9 |
4 |
p. |
artikel |
45 |
Understanding blood clot mechanical stability: the role of factor XIIIa-mediated fibrin crosslinking in rupture resistance
|
Ramanujam, Ranjini K. |
|
|
9 |
4 |
p. |
artikel |
46 |
Using a transformer language model to curate a pulmonary embolism dataset from the Medical Information Mart for Intensive Care IV: MIMIC-IV-Ext-PE
|
Lam, Barbara D. |
|
|
9 |
4 |
p. |
artikel |
47 |
Vascular-type heterogeneity is associated with differential gene expression profiles of endothelial cells under shear stress
|
Cox, Allaura A. |
|
|
9 |
4 |
p. |
artikel |
48 |
Weighing the consequences: body mass index trajectories after pediatric venous thromboembolism
|
Jaffray, Julie |
|
|
9 |
4 |
p. |
artikel |
49 |
ZO-2 seals the deal for platelet tight junctions
|
Zhang, Yiheng |
|
|
9 |
4 |
p. |
artikel |